Pieris Pharmaceuticals Cost of Goods Sold 1970-1969 | PVLA
Pieris Pharmaceuticals cost of goods sold from 1970 to 1969. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Pieris Pharmaceuticals Annual Cost of Goods Sold
(Millions of US $) |
Pieris Pharmaceuticals Quarterly Cost of Goods Sold
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
